Li, Y., Gong, Y., Ning, X., Peng, D., Liu, L., He, S., . . . Zhou, L. (2018). Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis. J Exp Clin Cancer Res.
Citação norma ChicagoLi, Yifan, et al. "Downregulation of CLDN7 Due to Promoter Hypermethylation Is Associated With Human Clear Cell Renal Cell Carcinoma Progression and Poor Prognosis." J Exp Clin Cancer Res 2018.
MLA citiranjeLi, Yifan, et al. "Downregulation of CLDN7 Due to Promoter Hypermethylation Is Associated With Human Clear Cell Renal Cell Carcinoma Progression and Poor Prognosis." J Exp Clin Cancer Res 2018.
Opozorilo: Ti citati niso vedno 100% točni.